Ito H, Yoshida H, Bogaki-Shonai M, Niga T, Hattori H, Nakamura S
Bioscience Research Laboratories, Dainippon Pharmaceutical Co., Ltd., Osaka, Japan.
Antimicrob Agents Chemother. 1994 Sep;38(9):2014-23. doi: 10.1128/AAC.38.9.2014.
A 6.4-kb DNA fragment containing the DNA gyrase gyrA and gyrB genes was cloned and sequenced from the quinolone-susceptible Staphylococcus aureus type strain ATCC 12600. An expression plasmid was constructed by inserting the cloned genes into the Escherichia coli-S. aureus shuttle vector pAT19, and deletion plasmids carrying only functional gyrA and gyrB genes were derived from this plasmid. An efficient transformation system for S. aureus RN4220 was established by using these plasmids. Quinolone-resistant mutants of S. aureus RN4220 were isolated by three-step selection with quinolones. The first- and second-step mutants were considered to be transport mutants, and the third-step mutants were divided into five groups with respect to their resistance patterns and transformation results with gyrA and gyrB genes. Sequencing analysis of the resulting mutant gyrase genes showed that they had the following point mutations: group 1, Ser-84 (TCA) to Leu (TTA) in GyrA; group 2, Ser-84 (TCA) to Ala (GCA), Ser-85 (TCT) to Pro (CCT), or Glu-88 (GAA) to Lys (AAA) in GyrA; group 3, Asp-437 (GAC) to Asn (AAC) in GyrB; group 4, Arg-458 (CGA) to Gln (CAA) in GyrB; and group 5, Ser-85 (TCT) to Pro (CCT) in GyrA and Asp-437 (GAC) to Asn (AAC) in GyrB. When the gyrA and/or gyrB mutants were transformed with the wild-type gyrA and/or gyrB plasmids, they became quinolone susceptible, but transformants with the plasmids having the same mutations on the gyrA and/or gyrB genes did not confer susceptibility. These results indicate that mutations in both gyrA and gyrB can be responsible for quinolone resistance in S. aureus.
从对喹诺酮敏感的金黄色葡萄球菌标准菌株ATCC 12600中克隆并测序了一个包含DNA促旋酶gyrA和gyrB基因的6.4 kb DNA片段。通过将克隆的基因插入大肠杆菌-金黄色葡萄球菌穿梭载体pAT19构建了一个表达质粒,并从该质粒衍生出仅携带功能性gyrA和gyrB基因的缺失质粒。利用这些质粒建立了一种针对金黄色葡萄球菌RN4220的高效转化系统。通过用喹诺酮进行三步筛选,分离出了金黄色葡萄球菌RN4220的喹诺酮抗性突变体。第一步和第二步突变体被认为是转运突变体,第三步突变体根据其抗性模式以及用gyrA和gyrB基因进行转化的结果被分为五组。对所得突变促旋酶基因的测序分析表明,它们具有以下点突变:第1组,GyrA中的Ser-84(TCA)突变为Leu(TTA);第2组,GyrA中的Ser-84(TCA)突变为Ala(GCA)、Ser-85(TCT)突变为Pro(CCT)或Glu-88(GAA)突变为Lys(AAA);第3组,GyrB中的Asp-437(GAC)突变为Asn(AAC);第4组,GyrB中的Arg-458(CGA)突变为Gln(CAA);第5组,GyrA中的Ser-85(TCT)突变为Pro(CCT)且GyrB中的Asp-437(GAC)突变为Asn(AAC)。当用野生型gyrA和/或gyrB质粒转化gyrA和/或gyrB突变体时,它们对喹诺酮变得敏感,但用在gyrA和/或gyrB基因上具有相同突变的质粒转化的菌株并未恢复敏感性。这些结果表明,gyrA和gyrB中的突变均可导致金黄色葡萄球菌对喹诺酮产生抗性。